Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819426 · ClinicalTrials.gov registry record · NA
Walking or High Intensity Exercise for Anxiety
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03819426: Completed NA study, sponsored by NYU Langone Health.
NCT03819426 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03819426, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
After an initial phone screen process, approximately 50 participants will be enrolled and evaluated/screened in person after consenting to achieve 30 eligible participants with a principal diagnosis of GAD, panic disorder, or social anxiety disorder and high anxiety sensitivity (Anxiety Sensitivity Index score =20). Participants will be given a choice of either high intensity interval training (HIIT) or walking interventions, which will be completed over the course of 8 weeks. The goal of the study is to 1) obtain pilot data comparing the efficacy of HIIT vs. walking for effects on psychiatric, functioning and immune outcomes, 2) to identify adherence levels given the choice of exercise intensity, and 3) to identify proportion of individuals opting for each intervention. Results from this pilot study will be used to inform future grant applications including a K award.
Primary Outcome
Scoring involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are stand alone items. The raw score ranges from 14 to 70.
Interventions
- BEHAVIORAL Low Intensity Exercise Intervention
- BEHAVIORAL High Intensity Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2020-07-29 |
| Phase | NA |
What the finished NCT03819426 record still lists
NCT03819426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Intensity Exercise Intervention is the first listed.
NCT03819426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03819426 about?
NCT03819426 is a clinical study titled "Walking or High Intensity Exercise for Anxiety". After an initial phone screen process, approximately 50 participants will be enrolled and evaluated/screened in person after consenting to achieve 30 eligible participants with a principal diagnosis of GAD, panic disorder, or social anxiety disorder and high anxiety sensitivity (Anxiety Sensitivity ...
What is the current status of trial NCT03819426?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-12-11. Estimated completion is 2020-07-29.
What interventions are being tested in trial NCT03819426?
The interventions under investigation include: Low Intensity Exercise Intervention (BEHAVIORAL), High Intensity Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03819426?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03819426's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI